[Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018002966
German
Original Title:
Kosten-Nutzen-Bewertung von Venlafaxin, Duloxetin, Bupropion und Mirtazapin im Vergleich zu weiteren verordnungsfaehigen medikamentoesen Behandlungen
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/g09-01.html
Year Published:
2013
URL for published report:
https://www.iqwig.de/download/G09-01_Abschlussbericht_Kosten-Nutzen-Bewertung-von-Venlafaxin-Duloxetin....pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Depression
- Depressive Disorder
- Venlafaxine Hydrochloride
- Duloxetine Hydrochloride
- Bupropion
- Mirtazapine
- Antidepressive Agents
- Cost-Benefit Analysis
Keywords
- Depression
- Depressive Disorder
- Venlafaxine
- Duloxetine
- Bupropion
- Mirtazapine
- Systematic Review
- Cost-Effectiveness Analysis
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.